Iwasaki Hideki, Gulam Shirol, Maeda Tomoji, Watanabe Mineo, Takajo Tokuko, Katsuyama Soh, Sano Hiroaki, Tominaga Takanari, Ogawa Akio, Sako Ken-Ichi, Takahashi Toru, Kawase Takahiro, Tsukahara Takamitsu, Matsuda Yoshikazu
Division of Clinical Pharmacology, Graduate School of Pharmaceutical Science, Nihon Pharmaceutical University, Ina 362-0806, Japan.
Raffinee International Inc., Tokyo 103-0023, Japan.
Medicina (Kaunas). 2025 Aug 22;61(9):1511. doi: 10.3390/medicina61091511.
: Kumazasa extract (KZExt) is a food product obtained by steam extraction of ( and ) leaves under high temperature and pressure. It contains abundant polyphenols, including -p-coumaric acid and ferulic acid, as well as xylooligosaccharides. In this study, we investigated the antibacterial, anti-viral, and anti-inflammatory effects of KZExt in vitro and in vivo. The anti-oxidant, antibacterial, and anti-viral effects of KZExt were assessed in vitro. Anti-oxidant activity was evaluated based on the scavenging of •OH, •O and O. Antibacterial effects were assessed by determining the minimum inhibitory concentration (MIC) using a microdilution method. Anti-influenza activity was measured via plaque formation in MDCK cells. Anti-inflammatory effects were assessed by measuring interleukin (IL)-1β inhibition in lipopolysaccharide (LPS)-stimulated RAW264.7 cells. In vivo, KZExt was administered once (30 min before) in a formalin-induced inflammation model to evaluate pain-related behavior. In the LPS-induced inflammation model, KZExt was administered for five days before LPS injection. Behavioral changes and cytokine levels were assessed 24 h later via the open field test and cytokine quantification. : In vitro, KZExt showed antibacterial, anti-influenza, and anti-oxidant effects, and suppressed LPS-induced IL-1β production. In vivo, it significantly reduced the second phase of formalin-induced pain behavior. In the LPS model, although behavioral changes were unaffected, KZExt suppressed IL-6 and interferon-γ production. : The antibacterial, anti-viral, and anti-inflammatory effects of KZExt were confirmed in vitro and in vivo. Notably, the anti-inflammatory effect suggests potential immunomodulatory activity. These findings indicate that KZExt may help suppress smoldering inflammation and inflammation associated with various diseases through its combined antibacterial, anti-viral, and immunomodulatory actions.
熊笹提取物(KZExt)是一种通过在高温高压下对(某植物)叶子进行蒸汽提取而获得的食品。它含有丰富的多酚类物质,包括对香豆酸和阿魏酸,以及低聚木糖。在本研究中,我们在体外和体内研究了KZExt的抗菌、抗病毒和抗炎作用。在体外评估了KZExt的抗氧化、抗菌和抗病毒作用。基于对•OH、•O和O的清除来评估抗氧化活性。通过使用微量稀释法测定最低抑菌浓度(MIC)来评估抗菌作用。通过在MDCK细胞中形成噬斑来测量抗流感活性。通过测量脂多糖(LPS)刺激的RAW264.7细胞中白细胞介素(IL)-1β的抑制情况来评估抗炎作用。在体内,在福尔马林诱导的炎症模型中单次给药KZExt(给药前30分钟)以评估疼痛相关行为。在LPS诱导的炎症模型中,在注射LPS前五天给予KZExt。24小时后通过旷场试验和细胞因子定量评估行为变化和细胞因子水平。在体外,KZExt表现出抗菌、抗流感和抗氧化作用,并抑制LPS诱导的IL-1β产生。在体内,它显著减轻了福尔马林诱导的疼痛行为的第二阶段。在LPS模型中,尽管行为变化未受影响,但KZExt抑制了IL-6和干扰素-γ的产生。KZExt的抗菌、抗病毒和抗炎作用在体外和体内均得到证实。值得注意的是,抗炎作用表明其具有潜在的免疫调节活性。这些发现表明,KZExt可能通过其抗菌、抗病毒和免疫调节作用的联合,有助于抑制慢性炎症以及与各种疾病相关的炎症。